LOS ANGELES, CA – Los Angeles is the latest destination in Biocair’s global expansion. The specialist courier continues to expand its operations, technology and personnel to meet the needs of a growing life sciences industry.
This move is the latest in Biocair’s rapid growth across the United States, Europe, Asia and South Africa. The company has invested in its global infrastructure throughout the COVID-19 pandemic, as the need for life sciences logistics continues to grow.
The new facility, situated near LAX, is equipped with a dedicated cell and gene therapy packaging station to meet the strict requirements for handling such valuable materials. With the latest packaging technology from SavSu and a state-of-the art liquid nitrogen service station, the local team can handle critical last-minute orders with ease.
Steve Canales, Biocair’s LAX Operations Manager, comments:
“We are very excited about what this new space offers, especially for our customers looking to ship cell and gene therapies and other time and temperature-sensitive materials. With more than triple the square footage as our previous space, we are improving the safety, efficiency and scalability of our entire operation.”
Biocair is a global GDP logistics specialist with over 35 years of experience in the pharmaceutical, biotechnology and life sciences sectors.
The company has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost effective solutions to all clients.
The Biocair network operates 24/7 in over 160 countries across Europe, Africa, Asia and the Americas.